Literature DB >> 18767147

Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors.

Carol Sweeney1, Kenneth M Boucher, Wade S Samowitz, Roger K Wolff, Hans Albertsen, Karen Curtin, Bette J Caan, Martha L Slattery.   

Abstract

Our understanding of somatic alterations in colon cancer has evolved from a concept of a series of events taking place in a single sequence to a recognition of multiple pathways. An oncogenetic tree is a model intended to describe the pathways and sequence of somatic alterations in carcinogenesis without assuming that tumors will fall in mutually exclusive categories. We applied this model to data on colon tumor somatic alterations. An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at CpG sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series. Oncogenetic tree analysis resulted in a reproducible tree with three branches. The model represents methylation of MINT markers as initiating a branch and predisposing to MSI, methylation of MHL1 and TP16, and BRAF mutation. APC mutation is the first alteration in an independent branch and is followed by TP53 mutation. KRAS2 mutation was placed a third independent branch, implying that it neither depends on, nor predisposes to, the other alterations. Individual tumors were observed to have alteration patterns representing every combination of one, two, or all three branches. The oncogenetic tree model assumptions are appropriate for the observed heterogeneity of colon tumors, and the model produces a useful visual schematic of the sequence of events in pathways of colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18767147      PMCID: PMC3742107          DOI: 10.1002/gcc.20614

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  58 in total

1.  Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)

Authors:  S Wadler; R Bajaj; D Neuberg; V Agarwal; H Haynes; A B Benson
Journal:  Cancer J Sci Am       Date:  1997 Sep-Oct

Review 2.  Colorectal cancer: a model for epigenetic tumorigenesis.

Authors:  J J L Wong; N J Hawkins; R L Ward
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

3.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Jennifer Herrick; Theodore R Levin; Carol Sweeney; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

4.  Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas.

Authors:  W S Samowitz; M L Slattery
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

5.  APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.

Authors:  Barry Iacopetta; Fabienne Grieu; Wei Li; Andrew Ruszkiewicz; Maria Caruso; James Moore; Goh Watanabe; Kazuyuki Kawakami
Journal:  Int J Cancer       Date:  2006-11-15       Impact factor: 7.396

6.  TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.

Authors:  A L Børresen-Dale; R A Lothe; G I Meling; P Hainaut; T O Rognum; E Skovlund
Journal:  Clin Cancer Res       Date:  1998-01       Impact factor: 12.531

7.  Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

Authors:  D J Ahnen; P Feigl; G Quan; C Fenoglio-Preiser; L C Lovato; P A Bunn; G Stemmerman; J D Wells; J S Macdonald; F L Meyskens
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

8.  Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.

Authors:  Michael J O'Brien; Shi Yang; Charline Mack; Huihong Xu; Christopher S Huang; Elizabeth Mulcahy; Mark Amorosino; Francis A Farraye
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

9.  Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.

Authors:  Martha L Slattery; Karen Curtin; Carol Sweeney; Theodore R Levin; John Potter; Roger K Wolff; Hans Albertsen; Wade S Samowitz
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

10.  BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.

Authors:  Wei Qi Li; Kazuyuki Kawakami; Andrew Ruszkiewicz; Graeme Bennett; James Moore; Barry Iacopetta
Journal:  Mol Cancer       Date:  2006-01-10       Impact factor: 27.401

View more
  18 in total

1.  Accurate reconstruction of the temporal order of mutations in neoplastic progression.

Authors:  Kathleen Sprouffske; John W Pepper; Carlo C Maley
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

Review 2.  Intrinsic cancer subtypes--next steps into personalized medicine.

Authors:  Cristina Santos; Rebeca Sanz-Pamplona; Ernest Nadal; Julieta Grasselli; Sonia Pernas; Rodrigo Dienstmann; Victor Moreno; Josep Tabernero; Ramon Salazar
Journal:  Cell Oncol (Dordr)       Date:  2015-01-14       Impact factor: 6.730

Review 3.  Enhancing cellular cancer vaccines.

Authors:  Edward P Cohen; Amla Chopra; InSug O-Sullivan; Tae Sung Kim
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

4.  KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications.

Authors:  Katharina Balschun; Jochen Haag; Ann-Kathrin Wenke; Witigo von Schönfels; Nicolas T Schwarz; Christoph Röcken
Journal:  J Mol Diagn       Date:  2011-05-04       Impact factor: 5.568

5.  Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women.

Authors:  Karen Curtin; Wade S Samowitz; Cornelia M Ulrich; Roger K Wolff; Jennifer S Herrick; Bette J Caan; Martha L Slattery
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

6.  Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.

Authors:  David Limsui; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Daniel J Weisenberger; Peter W Laird; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg
Journal:  Gut       Date:  2011-10-24       Impact factor: 23.059

7.  Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Authors:  Karen Curtin; Wade S Samowitz; Roger K Wolff; Cornelia M Ulrich; Bette J Caan; John D Potter; Martha L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

8.  Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study.

Authors:  Adam Naguib; Panagiota N Mitrou; Laura J Gay; James C Cooke; Robert N Luben; Richard Y Ball; Alison McTaggart; Mark J Arends; Sheila A Rodwell
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

9.  USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESS.

Authors:  Irina Ostrovnaya; Venkatraman E Seshan; Colin B Begg
Journal:  Ann Appl Stat       Date:  2015-11-02       Impact factor: 2.083

10.  Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.

Authors:  N Jewel Samadder; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Daniel J Weisenberger; Peter W Laird; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg
Journal:  Gastroenterology       Date:  2013-05-07       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.